Novo Nordisk has won the race to secure approval from the U.S. Food and Drug Administration for the first weight-loss drug to be administered orally. Jules Rimmer is a markets reporter in ...

Tesla officially began operations at its lithium refinery in Texas, Tesla CEO Elon Musk posted on social media last week. Will Austin voters get a say in whether or not the city moves forward with its ...

Editor’s note: Local news organizations aim offer a counterbalance to the seemingly ever-present division and controversy in headlines and online. Local news journalists at KXAN take pride in ...

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat diabetes, could help trim their ...

In the occupied Palestinian territories, the city of Beit Jala lit its Christmas tree in a powerful act of solidarity with Gaza, transforming a traditional celebration into a national message of hope, ...

“BRAT,” the fluorescent green-covered album that defined the summer of 2024 — colloquially known as “Brat Summer” — trickled back into the pop music zeitgeist on Nov. 20, when its creator, Charli xcx, ...

Novo Nordisk, which has stumbled through a bit of a manufacturing hangover at a former Catalent production site it picked up a year ago, was hit with a warning letter from the FDA last month. The ...

As both Novo Nordisk and Eli Lilly race to develop their long-anticipated oral GLP-1 obesity meds, a new report shows one taking a clear lead among potential prescribers. Spherix Global Insights ...

When Novo Nordisk launched Wegovy, its pioneering weight-loss jab, in America in June 2021, it felt like it was “running into a dark tunnel”, recalls Maziar Mike Doustdar, who took over as the Danish ...

Realistically, Brat Summer could live forever — but in the new trailer for Aidan Zamiri’s The Moment, Charli XCX doesn’t know if that’s what she even wants. The latest look into the film, which will ...

Motorsport legend Ken Block may no longer be with us after his tragic death nearly three years ago, but his spirit still burns through the tire smoke of Gymkhana. The latest installment sees rally ace ...

Novo Nordisk's trial to treat Alzheimer's with its GLP-1 drug failed. The company has been losing market share to Eli Lilly. Novo Nordisk also lost a bidding war for a promising start-up. Novo Nordisk ...